These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 12951354)
1. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis. Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354 [TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor? Chen SC; Lawrence RH; Byth K; Sorrell TC Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Harris A; Torres-Viera C; Venkataraman L; DeGirolami P; Samore M; Carmeli Y Clin Infect Dis; 1999 May; 28(5):1128-33. PubMed ID: 10452647 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105 [TBL] [Abstract][Full Text] [Related]
5. [Prevention and antibiotic treatment of Pseudomonas aeruginosa septicemia]. Deng GH Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):599-601, 637. PubMed ID: 8313182 [TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa. Hyatt JM; Schentag JJ Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S9-11. PubMed ID: 10654629 [TBL] [Abstract][Full Text] [Related]
7. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains. Elkhouly AE; el-Sokkary MA; el-Emam MA Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331 [No Abstract] [Full Text] [Related]
8. In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics. Dohar JE; Kenna MA; Wadowsky RM Am J Otol; 1996 Mar; 17(2):207-9. PubMed ID: 8723948 [TBL] [Abstract][Full Text] [Related]
9. Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients. Dick JD; Shull V; Karp JE; Valentine J Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S47-54. PubMed ID: 3127218 [TBL] [Abstract][Full Text] [Related]
10. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections. Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319 [TBL] [Abstract][Full Text] [Related]
11. [Loss of antibiotic sensitivity of Pseudomonas aeruginosa strains during treatment]. López-Yeste ML; Chaves J; Garau J; Martín A; Tirado M; Reig R; Roy C Med Clin (Barc); 1994 Jun; 103(3):81-4. PubMed ID: 8065221 [TBL] [Abstract][Full Text] [Related]
12. [Bacteremia with granulocytopenia--microbiology and empiric antibiotic treatment]. Hammerstrøm J; Jacobsen T Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4370-5. PubMed ID: 9889610 [TBL] [Abstract][Full Text] [Related]
13. [Infection by Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Descriptive study of 35 cases]. Elvira J; López-Suárez A; Clavo A; Piña JM; Segura E; Pérez-Guzmán E; Girón JA Enferm Infecc Microbiol Clin; 1998; 16(7):322-7. PubMed ID: 9808882 [TBL] [Abstract][Full Text] [Related]
14. Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides. Deziel-Evans LM; Murphy JE; Job ML Clin Pharm; 1986 Apr; 5(4):319-24. PubMed ID: 3709080 [TBL] [Abstract][Full Text] [Related]